b'Our EIS portfolioSubstantial investment track recordOXGENE Oxford Genetics Limited (trading as OXGENE), based in Oxford, is a Sense biotechnology company specialising in gene therapy, gene editing and antibody discovery that has delivered a third consecutive year of 100%+ Biodetection revenue growth.With operations in both the UK and the US, SenseThis continued growth has been fuelled by a combination of strategic licensing agreements and service delivery projects, including a strategic partnership with Fujifilm Diosynth Biotechnologies. The companys is focused on the development of instrument-freecontinued growth has been recognised recently by being included in The Sunday Times Fastest Growing molecular diagnostics delivering true point-of-careTech 100, at position 19.molecular testing.In October 2019 Sense raised 10.5m in Series A investments and concurrently secured a grant of 1.8m from Innovate UK.In March 2020, Sense announced an accelerated programme to launch the worlds first instrument-free, point-of-care molecular diagnostic test for COVID-19, partnering with Phillips-Medisize (a leading global medical device innovator, developer and manufacturer, owned by Molex) to scale up production of its testing to meet the growing demand for rapid diagnostics. In October of the same year the company also announced successful series B investment to support their scale up plans. VoxpopmeVoxpopme, Birmingham-founded, but US-based, Voxpopme is a videoinsights platform that provides innovative video analytics for internationally renowned clients such as Microsoft, Shell, Coca-Cola, Verizon and Expedia.The business has demonstrated continued growth in ARR over the six months to 30 September 2020 against the backdrop of COVID-19. In November 2020 Voxpopme secured a syndicated investment of 3.1m in which Mercia contributed a direct investment of 0.8m. This company demonstrates Mercias Complete Connected Capital in action as it has received investment from our EIS Funds, the Backing the businesses of tomorrow Northern VCT Funds as well as Mercias balance sheet.14 15'